Guardian Pharmacy Services (NYSE:GRDN) Upgraded by Zacks Research to Strong-Buy Rating

Zacks Research upgraded shares of Guardian Pharmacy Services (NYSE:GRDN) from a hold rating to a strong-buy rating in a research note published on Wednesday,Zacks.com reports.

Other research analysts have also recently issued reports about the company. Raymond James Financial restated an “outperform” rating and set a $40.00 price target on shares of Guardian Pharmacy Services in a research note on Thursday, March 12th. Truist Financial boosted their price objective on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Weiss Ratings reissued a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Stephens raised their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, January 14th. Finally, UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a research note on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $38.00.

Guardian Pharmacy Services Trading Up 1.5%

NYSE GRDN opened at $34.43 on Wednesday. The stock has a market cap of $2.18 billion, a PE ratio of 44.72 and a beta of 0.86. Guardian Pharmacy Services has a twelve month low of $19.17 and a twelve month high of $37.43. The stock has a fifty day simple moving average of $32.14 and a 200-day simple moving average of $29.60.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.10. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The business had revenue of $397.62 million during the quarter, compared to analysts’ expectations of $390.04 million. Guardian Pharmacy Services’s quarterly revenue was up 17.4% on a year-over-year basis. Research analysts predict that Guardian Pharmacy Services will post 0.87 EPS for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Large investors have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. raised its position in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares in the last quarter. California State Teachers Retirement System increased its stake in shares of Guardian Pharmacy Services by 3.4% during the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after buying an additional 593 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Guardian Pharmacy Services by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after buying an additional 805 shares during the period. Police & Firemen s Retirement System of New Jersey raised its holdings in Guardian Pharmacy Services by 20.4% in the fourth quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after acquiring an additional 1,028 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new position in Guardian Pharmacy Services in the third quarter worth approximately $30,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.